← Back to all articles
Clinical TrialsPubMed Verified

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study

Sanches RF, de Lima Osorio F, dos Santos RG, Macedo LR, Maia-de-Oliveira JP, Wichert-Ana L, de Araujo DB, Riba J, Crippa JA, Hallak JE

Journal of Clinical Psychopharmacology (2016)

Open-label trial
Abstract

SPECT neuroimaging study in 17 patients with recurrent depression. Ayahuasca increased blood flow in mood-regulating regions including nucleus accumbens, insula, and subgenual area.

Participants17
Citations230
Study TypeOpen-label trial
depressionSPECTneuroimagingcerebral blood flow
DOI: 10.1097/JCP.0000000000000436View on PubMed

Related Articles

Clinical Trials

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report

Osorio FL, Sanches RF et al.

Revista Brasileira de Psiquiatria, 2015
Clinical Trials

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial

Palhano-Fontes F, Barreto D et al.

Psychological Medicine, 2019
Clinical Trials

Ayahuasca improves self-perception of speech performance in subjects with social anxiety disorder: a pilot, proof-of-concept, randomized, placebo-controlled trial

Dos Santos RG, Osorio FL et al.

Journal of Clinical Psychopharmacology, 2021
Clinical Trials

Effects of ayahuasca on the recognition of facial expressions of emotions in naive healthy volunteers: a pilot, proof-of-concept, randomized controlled trial

Rocha JM, Rossi GN et al.

Journal of Clinical Psychopharmacology, 2021